Peter Gute
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 23
- HIV/AIDS Research and Interventions 15
- Virology 21
- HIV Research and Treatment 21
- Co-authors
- HR Brodt (3 shared papers)E. B. Helm (3 shared papers)Bernd S. Kamps (1 shared paper)Veronica Miller (5 shared papers)Caroline Sabin (3 shared papers)Annemarie Berger (5 shared papers)Schlomo Staszewski (10 shared papers)Annette Haberl (8 shared papers)
- Journals
- HIV Medicine (4 papers)AIDS (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Medical Microbiology and Immunology (3 papers)Journal of Hepatology (2 papers)
- Partner nations
- GermanyUnited KingdomBelgium
In The Last Decade
Peter Gute
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Virology 688
- Infectious Diseases 868
- Emergency Medicine 216
- Epidemiology 308
- Hepatology 65
Countries citing papers authored by Peter Gute
This map shows the geographic impact of Peter Gute's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gute more than expected).
Fields of papers citing papers by Peter Gute
This network shows the impact of papers produced by Peter Gute. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gute. The network helps show where Peter Gute may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Gute, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 322 | |
| 2 | 2000 | 165 | |
| 3 | 1999 | 114 | |
| 4 | 2000 | 65 | |
| 5 | 2008 | 52 | |
| 6 | 2012 | 52 | |
| 7 | 2006 | 34 | |
| 8 | 2013 | 31 | |
| 9 | 2014 | 29 | |
| 10 | 2006 | 29 | |
| 11 | 2007 | 24 | |
| 12 | 2004 | 23 | |
| 13 | 2004 | 22 | |
| 14 | Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users. | 1998 | 20 |
| 15 | 2002 | 20 | |
| 16 | 2012 | 19 | |
| 17 | 1994 | 18 | |
| 18 | 2007 | 17 | |
| 19 | 2008 | 17 | |
| 20 | 2016 | 16 |
About Peter Gute
Peter Gute is a scholar working on Infectious Diseases, Virology, Epidemiology, Hepatology and Emergency Medicine, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (21 papers), HIV/AIDS Research and Interventions (15 papers), Hepatitis C virus research (8 papers), HIV-related health complications and treatments (6 papers), Liver Disease Diagnosis and Treatment (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Virology (688 citations), Infectious Diseases (868 citations), Emergency Medicine (216 citations), Epidemiology (308 citations) and Hepatology (65 citations). Peter Gute has collaborated with scholars based in Germany, United Kingdom and Belgium. Frequent co-authors include HR Brodt, E. B. Helm, Bernd S. Kamps, Veronica Miller, Caroline Sabin, Annemarie Berger, Schlomo Staszewski, Annette Haberl, Andrew Phillips and Brendan Larder. Their work appears in journals such as HIV Medicine, AIDS, Journal of Antimicrobial Chemotherapy, Medical Microbiology and Immunology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.